Serum Opsonins to Serogroup B Meningococci in Meningococcal Disease

References

• Goldschneider I, Gotschlich E C, Artenstein M S. Human immunity to the meningococcus. I. The role of humoral antibodies. J Exp Med 1969; 129: 1307–1326
   PubMed Web of Science ®Google Scholar
• Goldschneider I, Gotschlich E C, Artenstein M S. Human immunity to the meningococcus. II. Development of natural immunity. J Exp Med 1969; 129: 1327–1348
   PubMed Web of Science ®Google Scholar
• Gotschlich E C, Goldschneider I, Artenstein M S. Human immunity to the meningococcus. IV. Immunogenicity of group A and group C meningococcal polysaccharides in human volunteers. J Exp Med 1969; 129: 1367–1384
   PubMed Web of Science ®Google Scholar
• Peltola H, Mäkelä P H, Käyhty H, Jousimies H, Herva E, Hällström K, Sivonen A, Renkonen O V, Pettay O, Karanko V, Ahvonen P, Sarna S. Clinical efficacy of meningococcus group A capsular polysaccharide vaccine in children three months to five years of age. N Engl J Med 1977; 297: 686–691
   PubMed Web of Science ®Google Scholar
• Griffiss JMcL. Epidemic meningococcal disease: Synthesis of a hypothetical immunoepidemiologic model. Rev Infect Dis 1982; 4: 159–172
   PubMedGoogle Scholar
• Wyle F A, Artenstein M S, Brandt B L, Tramont E C, Rasper D L, Altieri P L, Berman S L, Lowenthal J P. Immunologic response of man to group B meningococcal polysaccharide vaccines. J Infect Dis 1972; 126: 514–522
   PubMed Web of Science ®Google Scholar
• Zollinger W D, Mandrell R E. Importance of complement source in bactericidal activity of human antibody and murine monoclonal antibody to meningoccccal group B polysaccharide. Infect Immun 1983; 40: 257–264
   PubMed Web of Science ®Google Scholar
• Frasch C E, Tsai C M, Mocca L F. Outer membrane proteins of Neisseria meningitidis: Structure and importance in meningococcal disease. Clin Invest Med 1986; 9: 101–107
   PubMedGoogle Scholar
• Griffiss JMcL, Apicella M A, Greenwood B, Mäkelä P H. Vaccines against encapsulated bacteria: A global agenda. Rev Infect Dis 1987; 9: 176–188
   PubMedGoogle Scholar
• Frasch C E, Robbins J D. Protection against group B meningococcal disease. III. Immunogenicity of serotype 2 vaccines and specificity of protection in a guinea pig model. J Exp Med 1978; 147: 629–644
   PubMed Web of Science ®Google Scholar
• Craven D E, Shen K T, Frasch C E. Natural bactericidal activity of human serum against Neisseria meningitidis isolates of different serogroups and serotypes. Infect Immun 1982; 37: 132–137
   PubMedGoogle Scholar
• Ross S C, Rosenthal P J, Berberich H M, Densen P. Killing of Neisseria meningitidis by human neutrophils: Implications for normal and complement-deficient individuals. J Infect Dis 1987; 155: 1266–1275
   Google Scholar
• Halstensen A, Haneberg B. Standardization of a chemiluminescence method for the measurement of meningococcal opsonins using ethanol fixed meningococci. Acta Pathol Microbiol Immunol Scand [C] 1987; 95: 155–160
   PubMedGoogle Scholar
• Harthug S, Rosenqvist E, Høiby E A, Gedde-Dahl T W, Frøholm L O. Antibody response in group B meningococcal disease determined by enzyme-linked immunosorbent assay with serotype 15 outer membrane antigen. J Clin Microbiol 1986; 24: 947–953
   PubMedGoogle Scholar
• Sjursen H, Bjerknes R, Halstensen A, Næess A, Frøholm L O, Rosenqvist E, Solberg C O. Serum opsonins to group B meningococci. Acta Pathol Microbiol Immunol Scand [C] 1987; 95: 283–289
   PubMedGoogle Scholar
• Gedde-Dahl T W, Høiby E A, Schillinger A, Lystad A, Bøvre K. An epidemiological, clinical and microbiological follow–up study of incident meningococcal disease cases in Norway, winter 1981–1982. Material and epidemiology in the MenOPP project. NIPH Ann 1983; 6: 155–168
   PubMedGoogle Scholar
• Halstensen A, Pedersen S HJ, Haneberg B, Bjorvatn B, Solberg C O. Case fatality of meningococcal disease in Western Norway. Scand J Infect Dis 1987; 19: 35–42
   PubMed Web of Science ®Google Scholar
• Toews W H, Bass J W. Skin manifestation of meningococcal infection. An immediate indicator of prognosis. Am J Dis Child 1974; 127: 173–176
   PubMedGoogle Scholar
• Vik-Mo H, Lote K, Nordøy A. Disseminated intravascular coagulation in patients with meningococcal infection: Laboratory diagnosis and prognostic factors. Scand J Infect Dis 1978; 10: 187–191
   PubMed Web of Science ®Google Scholar
• Niklasson P-M, Lundbergh P, Strandell T. Prognostic factors in meningococcal disease. Scand J Infect Dis 1971; 3: 17–25
   PubMedGoogle Scholar
• Bjorvatn B, Bjertnæs L, Fadnes H O, Flægstad T, Gutteberg T J, Kristiansen B E, Pape J, Rekvig O P, Østerud B, Aanderud L. Meningococcal septicaemia treated with combined plasmapheresis and leucapheresis or with blood exchange. Br Med J 1984; 288: 439–441
   PubMed Web of Science ®Google Scholar
• Frøholm L O, Holten E, Poolman J T, Zollinger W D (1985) Typing of Norwegian meningococcal isolates and possible implications for serogroup B vaccination, The pathogenic neisseriae. Proceedings of the 4th international symposium. 1985, G K Schoolnik, G F Brooks, S Falkow, C E Frasch, J S Knapp, J A McCutchan, S A Morse. American Society for Microbiology, Washington, DC, 541–545
   Google Scholar
• Dixon W J, Brown M B, Engelman L, Frane J W, Hill M A, Jennrich R I, Toporek J D. BMDP statistical software manual. 1985 printing. University of California Press, Los Angeles, Ca 1985
   Google Scholar
• Laursen B, Faber V, Brock A, Gormsen J, Sørensen H. Disseminated intravascular coagulation, antithrombin III, and complement in meningococcal infections. Acta Med Scand 1981; 209: 221–227
   PubMedGoogle Scholar
• Gold R, Goldschneider I, Lepow M L, Draper T F, Randolph M. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children. J Infect Dis 1978; 137: 112–121
   PubMed Web of Science ®Google Scholar
• Bøvre K. Meningococcal infections—research and basis for control measures in Norway. A summarizing discussion of main topics from a symposium held on 29 April 1980 in Oslo. NIPH Ann 1980; 3/2: 109–125
   Google Scholar
• Munford R S, Taunay A E, Morals J S, Fraser D W, Feldman R A. Spread of meningococcal infection within households. Lancet 1974; 1: 1275–1278
   PubMed Web of Science ®Google Scholar
• Zollinger W D, Pennington C L, Artenstein M S. Human antibody response to three meningococcal outer membrane antigens: Comparison by specific hemagglutination assays. Infect Immun 1974; 10: 975–984
   PubMedGoogle Scholar
• Poolman J T, Hopman C TP, Zanen H C. Immunogenicity of meningococcal antigens as detected in patient sera. Infect Immun 1983; 40: 398–406
   PubMed Web of Science ®Google Scholar
• Halstensen A, Sjursen H, Frøholm L O, Høiby E A, Frasch C E, Zollinger W D. Immune response to meningococcal serogroup B polysaccharide and serotype 2a outer membrane complex vaccines. Gonococci and meningococci, J T Poolman, H C Zanen, T F Meyer, J E Heckels, P H Mäkelä, H Smith, E C Beuvery. Kluwer Academic Publishers, Dordrecht, the Netherlands 1988; 109–113
   Google Scholar
• Halstensen A, Haneberg B, Frøholm L O, Lehmann V, Frasch C E, Solberg C O. Human opsonins to meningococci after vaccination. Infect Immun 1985; 46: 673–676
   Google Scholar
• Griffiss JMcL, Brandt B L, Broud D D, Goroff D K, Baker C J. Immune response to infants and children to disseminated infections with Neisseria meningitidis. J Infect Dis 1984; 150: 71–79
   PubMed Web of Science ®Google Scholar
• Mæland J A, Smeland S. Examplification of serological crossreactivity of Neisseria lipopolysac-charides. Acta Pathol Microbiol Immunol Scand (B) 1986; 94: 223–229
   Google Scholar
• Wedege E, Frøholm L O. Human antibody response to a group B serotype 2a meningococcal vaccine determined by immunoblotting. Infect Immun 1986; 51: 571–578
   PubMedGoogle Scholar
• Lowell G H, Smith L F, Griffiss JMcL, Brandt B L, MacDermott R P. Antibody dependent mononuclear cell-mediated antimeningococcal activity. Comparison of the effects of convalescent and postimmunization immunoglobulins G, M and A. J Clin Invest 1980; 66: 260–267
   PubMedGoogle Scholar
• Jarvis G A, Vedros N A. Sialic acid of group B Neisseria meningitidis regulates alternative complement pathway activation. Infect Immun 1987; 55: 174–180
   PubMed Web of Science ®Google Scholar
• Ward K N, Fleer A, Verhoef J, Jones D M. Opsonization and phagocytosis of group B meningococci by polymorphonuclear leucocytes: Comparison of sulphonamide sensitive and resistant strains. J Clin Pathol 1987; 40: 361–367
   PubMedGoogle Scholar